DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Akuta N, Sezaki H, Suzuki F. , et al.
Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens.
J Med Virol 2017;
89 (07) 1248-1254
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.